Stock Alert: OraSure Technologies Shares Up 25%

(RTTNews) - Shares of OraSure Technologies Inc. (OSUR) are soaring over 25% Monday morning, after the company announced that its DNA Genotek subsidiary has received Emergency Use Authorization or EUA from the U.S. Food and Drug Administration or FDA for the use of DNA Genotek's OMNIgene·ORAL saliva collection and stabilization device in COVID-19 testing.

The company noted that this is the first FDA EUA that allows for the unsupervised use of the device at-home or in a healthcare setting when used as part of an approved or validated at-home test kit, meaning patients can safely collect their own sample, without the presence of a healthcare professional.

The stock has been trading in the range of $5.23 - $19.75 for the past one year, and is currently trading at $17.27, up $3.46 or 25.05%, with trading volume rising over 4.76 million versus an average volume of 2.19 million shares.